CA2542510A1 - Treatment of hypersensitivity conditions - Google Patents

Treatment of hypersensitivity conditions Download PDF

Info

Publication number
CA2542510A1
CA2542510A1 CA002542510A CA2542510A CA2542510A1 CA 2542510 A1 CA2542510 A1 CA 2542510A1 CA 002542510 A CA002542510 A CA 002542510A CA 2542510 A CA2542510 A CA 2542510A CA 2542510 A1 CA2542510 A1 CA 2542510A1
Authority
CA
Canada
Prior art keywords
side chain
compound
treatment
hypersensitivity
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002542510A
Other languages
English (en)
French (fr)
Inventor
Ian Alexander Shiels
Stephen Maxwell Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
University of Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Queensland filed Critical University of Queensland
Publication of CA2542510A1 publication Critical patent/CA2542510A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002542510A 2002-10-17 2003-10-16 Treatment of hypersensitivity conditions Abandoned CA2542510A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2002952129 2002-10-17
AU2002952129A AU2002952129A0 (en) 2002-10-17 2002-10-17 Treatment of hypersensitivity conditions
PCT/AU2003/001374 WO2004035080A1 (en) 2002-10-17 2003-10-16 Treatment of hypersensitivity conditions

Publications (1)

Publication Number Publication Date
CA2542510A1 true CA2542510A1 (en) 2004-04-29

Family

ID=28047696

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002542510A Abandoned CA2542510A1 (en) 2002-10-17 2003-10-16 Treatment of hypersensitivity conditions

Country Status (6)

Country Link
US (1) US20070021329A1 (enExample)
EP (1) EP1560592A4 (enExample)
JP (1) JP2006505556A (enExample)
AU (1) AU2002952129A0 (enExample)
CA (1) CA2542510A1 (enExample)
WO (1) WO2004035080A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS160602A0 (en) * 2002-04-08 2002-05-16 University Of Queensland, The Therapeutic method
AU2002952086A0 (en) * 2002-10-16 2002-11-07 The University Of Queensland Treatment of osteoarthritis
AU2003902586A0 (en) * 2003-05-26 2003-06-12 The University Of Queensland Treatment of burns
GB2477831B (en) * 2008-09-18 2013-03-27 Micromass Ltd Ion guide array
WO2010065671A2 (en) * 2008-12-04 2010-06-10 Curna, Inc. Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
WO2016104738A1 (ja) * 2014-12-26 2016-06-30 三菱レイヨン株式会社 ヒト以外の哺乳動物の皮膚疾患を治療する方法及び治療装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO755097A0 (en) * 1997-06-25 1997-07-17 University Of Queensland, The Receptor agonist and antagonist
US20020107197A1 (en) * 2000-09-20 2002-08-08 Yan Xu Ligands for G protein coupled receptors and methods of using them
AUPR833401A0 (en) * 2001-10-17 2001-11-08 University Of Queensland, The G protein-coupled receptor antagonists

Also Published As

Publication number Publication date
WO2004035080A1 (en) 2004-04-29
AU2002952129A0 (en) 2002-10-31
EP1560592A1 (en) 2005-08-10
EP1560592A4 (en) 2010-03-03
US20070021329A1 (en) 2007-01-25
JP2006505556A (ja) 2006-02-16

Similar Documents

Publication Publication Date Title
JP2810240B2 (ja) サイトカイン調節剤およびサイトカインレベルの変化に関連する病状および状態における使用方法
JP3902406B2 (ja) 老化防御効果を示すテトラペプチド、これを基にした薬理学的物質、及びその利用法
US7919459B2 (en) Use of C5a receptor antagonist in the treatment of fibrosis
US20090004264A1 (en) Methods for treating and ameliorating the symptons of inflammatory bowel diseases
US20100267639A1 (en) Treatment of osteoarthritis
EA021303B1 (ru) Способы лечения или профилактики рвоты с помощью агентов, усиливающих секрецию гормона роста
KR20070036033A (ko) 보체 Ｃ５ａ 수용체 조절제를 이용한 신경계 증상의치료방법
US20070021329A1 (en) Treatment of hypersensitivity conditions
AU2003266862B2 (en) Treatment of hypersensitivity conditions
AU2003266862A1 (en) Treatment of hypersensitivity conditions
CN101102816B (zh) 用于治疗肝性脑病的含有鸟氨酸和苯基乙酸（phenylacetate)或苯基丁酸（phenylbutyrate)的组合物
US20070054841A1 (en) Method of treatment of systemic injury secondary to burns
AU2003215446B2 (en) Use of C5a receptor antagonist in the treatment of fibrosis
WO1991015121A1 (en) Method for treating fungal infection
AU2003269602B2 (en) Treatment of inflammatory bowel disease
ES2366538T3 (es) Tratamiento de la enfermedad inflamatoria intestinal.
AU2004241673A1 (en) Method of treatment of systemic injury secondary to burns
AU2003269602A1 (en) Treatment of inflammatory bowel disease

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued